Table 3 Molecular data of Māori and NZ European sub-cohort of breast cancer patients.

HIF-1α

H-score ^c

14

75.5 (± 55.5)

14

75.2

(± 58.9)

0.36

(-34.4, 35.1)

0.02

13

0.98

GLUT-1

H-score ^c

14

112.9 (± 45.2)

14

120.4 (± 46.4)

-7.5

(-47.6, 32.6)

-0.40

13

0.69

CA-IX

H-score^c

14

56.6 (± 32.6)

14

64.0

(± 59.1)

-7.4

(-37.7, 22.9)

-0.53

13

0.61

MVD

high/low^d

14

5/14

(35.7%)

14

6/14

(42.9%)

7.2%

0.2

1

0.65

CK5/6

pos/neg ^d

14

2/14

(14.3%)

14

3/14

(21.4%)

7.1%

0.2

1

0.65

VEGF-A

pg/ml ^c

11

299.9 (± 162.7)

11

359.6 (± 174.8)

-59.8

(-134, 14.5)

-1.79

10

0.10

IGF-1

ng/ml ^c

11

114.5 (± 31.4)

11

100.6 (± 24.7)

14.0

(-12.4, 40.4)

1.18

10

0.27